Good evening :)
$
₹
InfuSystems Holdings Inc

InfuSystems Holdings Inc

INFU

AMEX
Asset Logo

InfuSystems Holdings Inc

INFU

AMEX
$13.890.33% (-0.04)
$
₹
$13.890.33% (-0.04)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Devices

Micro Cap

With a market cap of $277.6M the stock is ranked 3885

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

34.85
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.82
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.4
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.73
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

5.96%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 4 analysts reports

Buy
4 analysts
Hold
0 analyst
Sell
0 analyst

Price Upside

+20.76%

Earnings Growth

-8%

Rev. Growth

+1.2%

See Detailed Forecast

Company Profile

Company Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.59
24.59
1Y Return
15.29%
15.29%
Buy Reco %
92.59
92.59
Cigna Corp
CI
Cigna Corp
P/E Ratio
12.68
12.68
1Y Return
0.61%
0.61%
Buy Reco %
75.00
75.00
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
24.09
24.09
1Y Return
32.01%
32.01%
Buy Reco %
52.94
52.94
Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings
P/E Ratio
27.20
27.20
1Y Return
16.13%
16.13%
Buy Reco %
72.22
72.22
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
143.8%
143.8%
Buy Reco %
96.15
96.15
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Higher price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 20.76% growth, versus a trailing 3-year CAGR of 14.94%.

2026
Current$13.94Baseline
Analyst Target - 1 year
Target$16.83+20.76%

All values in $

202220232024202520262027$10.33$13.06$15.79Target+20.76%
2026
Current$13.94Baseline
Analyst Target - 1 year
Target$16.83+20.76%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies 1.20% growth, versus a trailing 3-year CAGR of 9.28%.

2025
Current$143.43Baseline
Forecast for Dec 2026
High$145.57+1.49%
Average$145.16+1.2%
Low$144.61+0.82%

All values in $ Million

202120222023202420252026102.38109.91125.78134.86143.43Low+0.82%Average+1.2%High+1.49%
2025
Current$143.43Baseline
Forecast for Dec 2026
High$145.57+1.49%
Average$145.16+1.2%
Low$144.61+0.82%

All values in $ Million

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -8.00% growth, versus a trailing 3-year CAGR of 268.40%.

2025
Current$0.5Baseline
Forecast for Dec 2026
High$0.46-8%
Average$0.46-8%
Low$0.46-8%

All values in $

2021202220232024202520260.080.010.090.180.5Low-8%Average-8%High-8%
2025
Current$0.5Baseline
Forecast for Dec 2026
High$0.46-8%
Average$0.46-8%
Low$0.46-8%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

36.4
2.2
36.2
2
33.6
1
36.9
3.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue31.9933.6935.3233.8434.713636.4836.2333.6836.93
Net Income-1.110.711.800.93-0.262.592.252.031.013.23
Net Profit Margin-3.47%2.12%5.11%2.75%-0.76%7.21%6.19%5.61%3.01%8.74%
See CostsAll values in $ Million

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
InfuSystems Holdings Inc 34.853.821.73
CVS Health Corp24.591.440.21
Cigna Corp12.681.710.75
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare INFU with any stock or ETF
Compare INFU with any stock or ETF
Comparing from
INFU
CVS
CI
Loading...

Frequently asked questions

  1. InfuSystems Holdings Inc (INFU) share price today is $13.89 as of October 26, 2026 at 11:14 PM IST. The stock touched a day high of $14.14 and a day low of $13.85.

  2. InfuSystems Holdings Inc stock trades on AMEX under the ticker symbol INFU.

  3. InfuSystems Holdings Inc's market capitalization is $277.64M as of October 26, 2026 at 11:14 PM IST.

  4. InfuSystems Holdings Inc's price-to-earnings (P/E) ratio is 34.85 as of October 26, 2026.

  5. InfuSystems Holdings Inc's price-to-book (P/B) ratio is 3.82 as of October 26, 2026.

  6. Yes, You can buy InfuSystems Holdings Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy InfuSystems Holdings Inc shares in three steps: 1. Search InfuSystems Holdings Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since InfuSystems Holdings Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in InfuSystems Holdings Inc (INFU) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.7197 shares at the current price of $13.89.

Loading...